Key result
Captopril and nitrendipine increase adenylyl cyclase activity and reduce Gi alpha in hypertensive rats.
Why the study?
Does pharmacological treatment with captopril, nitrendipine, or both improve myocardial heterologous adenylyl cyclase desensitization in spontaneously hypertensive rats?
Does pharmacological treatment with captopril, nitrendipine, or both improve myocardial heterologous adenylyl cyclase desensitization in spontaneously hypertensive rats?
Pharmacological treatment with captopril and/or nitrendipine reverses adenylyl cyclase desensitization in spontaneously hypertensive rats by reducing Gi alpha, potentially mitigating contractile dysfunction.
Answers are grounded in this paper and cite their sources.
May mitigate contractile dysfunction in hypertensive models; leaves open translation to human therapy.
We investigated the effect of pharmacological treatment with captopril, nitrendipine, and captopril plus nitrendipine on myocardial heterologous adenylyl cyclase desensitization and the underlying postreceptor defects in spontaneously hypertensive rats (SHR). In myocardial membranes from SHR, stimulation of adenylyl cyclase with guanylylimido-diphosphate (P < .001) and forskolin (P < .05) was significantly reduced, whereas no difference with forskolin was obtained in the presence of manganese chloride. Reconstitution of Gs alpha into Gs alpha-deficient S49 cyc- mouse lymphoma cells revealed no difference between SHR and control rats. In contrast, pertussis toxin labeling of Gi alpha was significantly increased in SHR. The reduction of adenylyl cyclase in SHR was abolished after pertussis toxin treatment of membranes. Treatment with captopril, nitrendipine, or both reduced Gi alpha and increased guanylylimidodiphosphate-stimulated adenylyl cyclase activity in SHR. In summary, heterologous adenylyl cyclase desensitization due to an increase of Gi alpha but in the presence of an unchanged activity of Gs alpha or the catalyst occurs in SHR. This alteration, which could contribute to the progression of contractile dysfunction by producing adrenergic subsensitivity, is sensitive to pharmacological treatment most likely because of a reduction of sympathetic activity.
No takes yet. Share an insight, caveat, or question.
Böhm et al. (1995) studied Hypertensive cardiac hypertrophy. Captopril, nitrendipine, and captopril plus nitrendipine vs. Control rats / untreated SHR was evaluated on Myocardial heterologous adenylyl cyclase desensitization and underlying postreceptor defects. Treatment with captopril, nitrendipine, or both reduced Gi alpha and increased guanylylimidodiphosphate-stimulated adenylyl cyclase activity in spontaneously hypertensive rats.
Synapse has enriched 10 related papers. Consider them for comparative context: